Healthcare Payers Split On Promoting OTC Statin Use – Survey
This article was originally published in The Tan Sheet
Executive Summary
Half of healthcare payers questioned in a recent survey say they would educate members about nonprescription statins if an OTC product were to reach the market, according to a report in the November/December Journal of Managed Care Pharmacy
You may also be interested in...
Mevacor Panelists Discuss Rx Formulary, OTC Cost Concerns
Mevacor Daily could complicate physician prescribing practices related to prior authorization for Rx statins if the drug were approved for over-the-counter sale
Mevacor Panelists Discuss Rx Formulary, OTC Cost Concerns
Mevacor Daily could complicate physician prescribing practices related to prior authorization for Rx statins if the drug were approved for over-the-counter sale
Mevacor Panelists Discuss Rx Formulary, OTC Cost Concerns
Mevacor Daily could complicate physician prescribing practices related to prior authorization for Rx statins if the drug were approved for over-the-counter sale